ZTS:NYSE
Zoetis Inc
$73.68
arrow_upward
+0.01%(+0.0050) 1D
Sep 15, 12:19:41 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
$72.91
High
$73.78
Low
$72.72
Mkt. cap
30.44B
Avg. vol.
5.98M
Volume
1.36M
Dividend
2.88%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
12.12
52-wk high
$149.54
52-wk low
$71.00
EPS
$6.08
Beta
0.73
Shares outstanding
413.22M
No. of employees
14K
Open
$72.91
High
$73.78
Low
$72.72
Mkt. cap
30.44B
Avg. vol.
5.98M
Volume
1.36M
Dividend
2.88%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
12.12
52-wk high
$149.54
52-wk low
$71.00
EPS
$6.08
Beta
0.73
Shares outstanding
413.22M
No. of employees
14K
News stories
From web sources and news partners
TradingView
·
20 hours ago
ZTS: Innovation and targeted pricing drive resilience amid pet care headwinds and strong livestock growth
Investing.com
·
21 hours ago
Zoetis at Morgan Stanley conference: pipeline offsets near-term pressure
ChartMill
·
1 day ago
Zoetis (NYSE:ZTS): A Quality Dividend Stock for Dividend Investors
Stock Traders Daily
·
1 day ago
Technical Reactions to ZTS Trends in Macro Strategies
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5K
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorPharmaceutical industry
Websitezoetis.com